In addition, cribriform prostate cancer possesses other unique molecular and genetic features; for example, p63, high molecular weight cytokeratin, and TMPRSS2-ERG gene fusion are reportedly significantly more common in cribriform tumors than non-cribriform tumors [55, 56]. This evidence concerns the gene TMPRSS2 and prostate carcinoma.